☆ 4.4 Letter

Seven years of chronic hepatitis C virus infection in an HIV-infected man without detectable antibodies

AIDS (2015)

Journal

AIDS

Volume 29, Issue 3, Pages 389-390

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1097/QAD.0000000000000541

Keywords

-

Categories

Immunology Infectious Diseases Virology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Genetics & Heredity

Growth history of hepatitis C virus among HIV/HCV co-infected patients in Guizhou Province

Xiu-Cheng Yang, Zhang-Ping Hong, Yi Wang, Nan Meng, Yong Hu, Qian-Yu Xiong, Da-Wen Qin, Du Shen, Xing-Lin Yang

Summary: This study investigated the molecular epidemiology and evolutionary dynamics of HCV among HIV/HCV co-infected individuals in Guizhou Province, China. The major HCV subtypes in this region were identified as 1b, 3a, 3b, and 6a, with 6a being the most dominant subtype. Phylogeographic analysis revealed that 6a originated from Yunnan and Guangxi provinces, while 3b emerged from the IDU network in Yunnan. Subtype 6a has shown a rapid population growth in Guizhou since 2004, with a slower growth rate in recent years.

FRONTIERS IN GENETICS (2023)

Add to Collection

Article Multidisciplinary Sciences

Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal

Lok Bahadur Shrestha, Gopal K. Yadav, Saugat Pradhan, Abhilasha Sharma, Tejendra Pandit, Roshan Chhetry, Basudha Khanal

Summary: This study aimed to analyze the prevalence and risk factors associated with co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-positive patients with regard to their CD4+ T cell status. The results indicated that intravenous drug use and lower CD4+ T cell count were the major risk predictors of co-infection.

PLOS ONE (2022)

Add to Collection

Article Cell Biology

Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells

Evan D. Rossignol, Anne-Sophie Dugast, Hacheming Compere, Christopher A. Cottrell, Jeffrey Copps, Shu Lin, Deniz Cizmeci, Michael S. Seaman, Margaret E. Ackerman, Andrew B. Ward, Galit Alter, Boris Julg

Summary: The study reveals differences in cell recognition and Fc functionality of HIV monoclonal antibodies derived from HIV controllers and broadly neutralizing antibodies. V3-loop targeting antibodies are prominent among the top cell binders, indicating potential selective exposure of V3-loop on the cell surface.

CELL REPORTS (2021)

Add to Collection

Article Microbiology

SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice

Sherif A. El-Kafrawy, Abby Odle, Aymn T. Abbas, Ahmed M. Hassan, Umama A. Abdel-Dayem, Arooj K. Qureshi, Lok-Yin Roy Wong, Jian Zheng, David K. Meyerholz, Stanley Perlman, Alimuddin Zumla, Esam Azhar

Summary: The use of IgY antibodies from chickens has shown prophylactic efficacy against SARS-CoV-2 in mice, reducing viral replication, morbidity, and lung pathology.

PLOS PATHOGENS (2022)

Add to Collection

Article Immunology

Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy

Claudia Hawkins, Minhee Kang, Debika Bhattacharya, Gavin Cloherty, Mary Kuhns, Roy Matining, Chloe Thio, Wadzanai Samaneka, Lameck Chinula, Nyirenda Mulinda, Sharlaa Badal-Faesen, Patcharaphan Sugandhavesa, Javier Lama, Simani Gaseitsiwe, Vera Holzmayer, Mark Anderson, Robert Murphy, Marion Peters

Summary: This study aims to identify serum biomarkers that assess the HBV cccDNA reservoir and predict functional cure in HIV/HBV co-infection. The results support the use of TDF-based DUAL-HBV active ART as the initial treatment option for HIV/HBV co-infection and suggest that HBV RNA could be a useful marker for evaluating treatment response in these patients.

AIDS (2022)

Add to Collection

Article Cell Biology

Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor

Kelsey A. Pilewski, Steven Wall, Simone I. Richardson, Nelia P. Manamela, Kaitlyn Clark, Tandile Hermanus, Elad Binshtein, Rohit Venkat, Giuseppe A. Sautto, Kevin J. Kramer, Andrea R. Shiakolas, Ian Setliff, Jordan Salas, Rutendo E. Mapengo, Naveen Suryadevara, John R. Brannon, Connor J. Beebout, Rob Parks, Nagarajan Raju, Nicole Frumento, Lauren M. Walker, Emilee Friedman Fechter, Juliana S. Qin, Amyn A. Murji, Katarzyna Janowska, Bhishem Thakur, Jared Lindenberger, Aaron J. May, Xiao Huang, Salam Sammour, Priyamvada Acharya, Robert H. Carnahan, Ted M. Ross, Barton F. Haynes, Maria Hadjifrangiskou, James E. Crowe Jr, Justin R. Bailey, Spyros Kalams, Lynn Morris, Ivelin S. Georgiev

Summary: In a study of a chronically HIV-1/HCV co-infected individual, researchers identified five cross-reactive antibodies that show exceptional neutralization breadth and effector functions against both HIV-1 and HCV. One antibody also cross-reacts with influenza and coronaviruses, including SARS-CoV-2. The development of these antibodies is closely related to somatic hypermutation, providing potential directions for therapeutic and vaccine development against current and emerging infectious diseases. Chronic co-infection represents a complex immunological challenge that can provide insights into the fundamental rules of antibody-antigen specificity.

CELL REPORTS (2023)

Add to Collection

Article Cell Biology

Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity

Annemarie Laumaea, Lorie Marchitto, Shilei Ding, Guillaume Beaudoin-Bussieres, Jeremie Prevost, Romain Gasser, Debashree Chatterjee, Gabrielle Gendron-Lepage, Halima Medjahed, Hung-Ching Chen, Amos B. Smith III, Haitao Ding, John C. Kappes, Beatrice H. Hahn, Frank Kirchhoff, Jonathan Richard, Ralf Duerr, Andres Finzi

Summary: The conformation of HIV-1 envelope (Env) determines the susceptibility of infected CD4(+) T cells to antibody-dependent cellular cytotoxicity (ADCC). The downregulation of CD4 on infected macrophages by Nef, Vpu, and Env has a lesser impact on Env conformation and ADCC sensitivity compared to CD4(+) T cells. However, treatment of infected macrophages with small CD4 mimetics exposes vulnerable CD4-induced Env epitopes and sensitizes them to ADCC.

CELL REPORTS (2023)

Add to Collection

Article Infectious Diseases

Prevalence of hepatitis B virus infection in pregnant women with and without HIV in Jos, Nigeria

Francis A. Magaji, Mark O. Okolo, Esther S. Yiltok, William Golit, Stephen A. Anzaku, Jerry Ogwuche, Victor C. Pam, Amaka N. Ocheke, Jonah Musa, Christien Isichie, Godwin E. Imade, Josiah T. Mutihir, Benjamin T. Ugwu, Ohei Agbaji, Solomon A. Sagay, Ayuba I. Zoakah, Susan E. Cohn

Summary: The study compared the prevalence of hepatitis B virus (HBV) in pregnant women with and without HIV in Jos, Nigeria, revealing a higher prevalence of HBV in pregnant women with HIV. Predictive factors for HBV infection included multiple pregnancies, registering for antenatal care before 20 weeks of gestation, and lacking prior HBV vaccination.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer

Jelle van Schooten, Anna Schorcht, Elinaz Farokhi, Jeffrey C. Umotoy, Hongmei Gao, Tom L. G. M. van den Kerkhof, Jessica Dorning, Tim G. Rijkhold Meesters, Patricia van der Woude, Judith A. Burger, Tom Bijl, Riham Ghalaiyini, Alba Torrents de la Pena, Hannah L. Turner, Celia C. Labranche, Robyn L. Stanfield, Devin Sok, Hanneke Schuitemaker, David C. Montefiori, Dennis R. Burton, Gabriel Ozorowski, Michael S. Seaman, Ian A. Wilson, Rogier W. Sanders, Andrew B. Ward, Marit J. van Gils

Summary: This study found that different antibody lineages target different epitopes on HIV-1 Env in an HIV-1 infected individual. The results show that these antibody lineages complement each other, resulting in a serum response with broad and potent neutralizing ability against HIV-1. Therefore, inducing combinations of moderately broad antibodies may be an effective vaccine strategy.

PLOS PATHOGENS (2022)

Add to Collection

Article Immunology

Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response

Anais Corma-Gomez, Juan Macias, Francisco Tellez, Luis Morano, Antonio Rivero, Miriam Serrano, Maria Jose Rios, Francisco Jesus Vera-Mendez, Marta Santos, Luis Miguel Real, Rosario Palacios, Ignacio de Los Santos, Paloma Geijo, Arkaitz Imaz, Dolores Merino, Maria Jose Galindo, Sergio Reus-Banuls, Miguel Angel Lopez-Ruz, Carlos Galera, Juan A. Pineda

Summary: The study found that the majority of HCV-infected patients develop liver complications within 3 years after achieving sustained virological response, with hepatic encephalopathy and ascites not usually emerging after this period. On the other hand, hepatocellular carcinoma and portal hypertension gastrointestinal bleeding may occur in the longer term.

AIDS (2021)

Add to Collection

Article Immunology

Serological response with Heplisav-B® in prior Hepatitis B vaccine non-responders living with HIV

Rebecca Khaimova, Briann Fischetti, Rebecca Cope, Leonard Berkowitz, Anjali Bakshi

Summary: This study evaluated the seroconversion rate following Heplisav-B (R) administration in PLWH with previous HBV vaccination failure. Results showed that Heplisav-B (R) was highly effective in achieving immunity to HBV in PLWH who failed non-adjuvanted recombinant vaccines.

VACCINE (2021)

Add to Collection

Article Virology

Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without non-Hodgkin lymphoma

Ke Zhuang, Yongxi Zhang, Pingzheng Mo, Liping Deng, Yong Jiang, Lei Yu, Fanghua Mei, Shaoxin Huang, Xi Chen, Yajun Yan, Hongbin Tang, Xiangdong Li, Yong Xiong, Shuwen Wu, Hengning Ke, Xien Gui, Ke Lan

Summary: The identification of differentially expressed proteins in the plasma of patients with AIDS-NHL may lead to the development of biomarkers for screening, diagnosis, treatment, and prognosis. Immunoglobulin and complement components were found to be common proteins in this study. These proteins play a role in the pathogenesis of AIDS-NHL.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Cell Biology

Alterations in high-dimensional T-cell profile and gene signature of immune aging in HIV-infected older adults without viremia

Min Sun Shin, Hong-Jai Park, Syim Salahuddin, Ruth R. Montgomery, Brinda Emu, Albert C. Shaw, Insoo Kang

Summary: Alterations in the immune system occur with aging and HIV infection can further impact immunosenescence in older individuals. This study found that older HIV-infected individuals without detectable viremia on antiretroviral therapy (ART) had increased expression of aging-associated genes and immune alterations in peripheral blood mononuclear cells (PBMCs), indicating a persistent impact of HIV infection on senescence in older HIV-infected individuals.

AGING CELL (2022)

Add to Collection

Article Virology

HIV-Infected Macrophages Are Infected and Killed by the Interferon-Sensitive Rhabdovirus MG1

Teslin S. Sandstrom, Nischal Ranganath, Stephanie C. Burke Schinkel, Syim Salahuddin, Oussama Meziane, Sandra C. Cote, Cecilia T. Costiniuk, Mohammad-Ali Jenabian, Jonathan B. Angel

Summary: The study demonstrates that an engineered rhabdovirus can preferentially infect and kill HIV-infected macrophages, potentially providing a novel approach to an HIV-1 cure. By targeting impaired antiviral signaling pathways in infected cells, the virus shows promise for adaptation in the HIV-1 cure field.

JOURNAL OF VIROLOGY (2021)

Add to Collection

Letter Immunology

Anthemosoma garnhami in an HIV-Infected Man from Zimbabwe Living in South Africa

David Stead, Desiree du Plessis, Lisa Ming Sun, John Frean

Summary: A study revealed that an HIV-positive man from Zimbabwe living in South Africa was infected with an African rodent piroplasm, Anthemosoma garnhami, expanding the known geographic and host range of this parasite.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

Nadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, Jose M. Miro, Katharina Grabmeier-Pfistershammer, Gilles Wandeler, Colette Smith, Stephane De Wit, Ferdinand Wit, Annegret Pelchen-Matthews, Cristina Mussini, Antonella Castagna, Christian Pradier, Antonella D'Arminio Monforte, Jorg Vehreschild, Anders Sonnerborg, Alain Anne, Andrew Carr, Loveleen Bansi-Matharu, Jens Lundgren, Harmony Garges, Felipe Rogatto, Robert Zangerle, Huldrych F. Gunthard, Line D. Rasmussen, Coca Nescoi, Marc Van der Valk, Marianna Menozzi, Camilla Muccini, Amanda Mocroft, Lars Peters, Lene Ryom

Summary: This study assessed the association between ABC and CVD in people with HIV. The results showed that recent ABC use was associated with a higher incidence of CVD. This association was not explained by the presence of pre-existing CVD or CKD risk.

AIDS (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Intentional- but not Unintentional Medication Non-adherence was Related with Beliefs about Medicines Among a Multi-Ethnic Sample of People with HIV

Anjuly Castelan, Jeannine F. Nellen, Marc van der Valk, Pythia T. Nieuwkerk

Summary: This study investigated the prevalence of intentional and unintentional non-adherence to antiretroviral therapy among people with HIV, and found that younger age was associated with both types of non-adherence. Intentional non-adherence was also associated with being a migrant from specific regions, having concerns about negative effects of the medication, and strong beliefs about overuse of medicines in general.

AIDS AND BEHAVIOR (2023)

Add to Collection

Article Immunology

The role of HIV/hepatitis B virus/hepatitis C virus RNA plus triple infection in end-stage liver disease and all-cause mortality in Europe

Amanda Mocroft, Adam Geressu, Charles Beguelin, Josep M. Llibre, Jeffrey V. Lazarus, Janez Tomazic, Jelena Smidt, Milosz Parczewski, Johanna Braennstroem, Dalibor Sedlacek, Olaf Degen, Marc van der Valk, Dzmitry Paduta, Leo Flamholc, Patrick Schmid, Chloe Orkin, Lars N. Nielsen, Christian Hoffmann, Marek Beniowski, Cristiana Oprea, Josip Begovac, Lars Peters

Summary: Limited data on end-stage liver disease (ESLD) and mortality in people with HIV (PWH) coinfected with both hepatitis B virus (HBV) and hepatitis C virus (HCV) were analyzed. The study found that HIV/HBV-coinfected individuals had lower rates of ESLD, while HIV/HBV/HCV-coinfected individuals had higher rates of ESLD compared with those with HIV/HCV. Over time, the incidence of ESLD decreased in all groups.

AIDS (2023)

Add to Collection

Article Gastroenterology & Hepatology

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

Bernard Surial, Adria Ramirez Mena, Marie Roumet, Andreas Limacher, Colette Smit, Olivier Leleux, Amanda Mocroft, Marc van der Valk, Fabrice Bonnet, Lars Peters, Juergen K. Rockstroh, Huldrych F. Guenthard, Annalisa Berzigotti, Andri Rauch, Gilles Wandeler

Summary: HBV coinfection is the most important cause of hepatocellular carcinoma (HCC) among people living with HIV (PLWH). While risk prediction tools for HCC have been validated in patients with HBV monoinfection, they have not been evaluated in PLWH. This study performed an external validation of PAGE-B in PLWH with HBV coinfection, and found that PAGE-B is a valid tool to determine the need for HCC screening.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Letter Gastroenterology & Hepatology

Unmasking a hepatitis C genotype 3a/1b dual infection in an individual treated with elbasvir/grazoprevir

Rob W. van der Pluijm, Loek P. Smits, Sjoerd P. Rebers, Janke Schinkel, Marc van der Valk

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Immunology

Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination

Marlou J. Jongkees, Daryl Geers, Kathryn S. Hensley, Wesley Huisman, Corine H. GeurtsvanKessel, Susanne Bogers, Lennert Gommers, Grigorios Papageorgiou, Simon P. Jochems, Jan G. den Hollander, Emile F. Schippers, Heidi S. M. Ammerlaan, Wouter F. W. Bierman, Marc van der Valk, Marvin A. H. Berrevoets, Robert Soetekouw, Nienke Langebeek, Anke H. W. Bruns, Eliane M. S. Leyten, Kim C. E. Sigaloff, Marit G. A. van Vonderen, Corine E. Delsing, Judith Branger, Peter D. Katsikis, Yvonne M. Mueller, Rory D. de Vries, Bart J. A. Rijnders, Kees Brinkman, Casper Rokx, Anna H. E. Roukens

Summary: The COVIH study examined the immune response of 1154 people with HIV who received COVID-19 vaccination, and found that 14% had reduced antibody levels after primary vaccination. Additional mRNA-1273 vaccination was shown to significantly enhance immune responses in 97% of participants, increasing antibody levels and specific immune cell populations.

JOURNAL OF INFECTIOUS DISEASES (2023)

Add to Collection

Correction Medicine, General & Internal

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study (vol 19, e1003979, 2022)

Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, Corine H. GeurtsvanKessel, Yvonne M. Mueller, Virgil A. S. H. Dalm, Grigorios Papageorgiou, Hanka Steggink, Alicja Gorska, Susanne Bogers, Jan G. den Hollander, Wouter F. W. Bierman, Luc B. S. Gelinck, Emile F. Schippers, Heidi S. M. Ammerlaan, Marc van der Valk, Marit G. A. van Vonderen, Corine E. Delsing, Elisabeth H. Gisolf, Anke H. W. Bruns, Fanny N. Lauw, Marvin A. H. Berrevoets, Kim C. E. Sigaloff, Robert Soetekouw, Judith Branger, Quirijn de Mast, Adriana J. J. Lammers, Selwyn H. Lowe, Rory D. de Vries, Peter D. Katsikis, Bart J. A. Rijnders, Kees Brinkman, Anna H. E. Roukens, Casper Rokx

PLOS MEDICINE (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey)

Nicole H. T. M. Dukers-Muijrers, Ymke Evers, Veja Widdershoven, Udi Davidovich, Philippe C. G. Adam, Eline L. M. op de Coul, Paul Zantkuijl, Amy Matser, Maria Prins, Henry J. C. de Vries, Casper den Heijer, Christian J. P. A. Hoebe, Anne-Marie Niekamp, Francine Schneider, Juliana Reyes-Uruena, Roberto Croci, Angelo D'Ambrosio, Marc van der Valk, Dirk Posthouwer, Robin Ackens, Henriette ter Waarbeek, Teymur Noori, Elske Hoornenborg

Summary: This study investigated vaccine acceptance and its determinants among gay, bisexual, and other men who have sex with men, including transgender individuals in the Netherlands. The results showed that 81.5% of respondents were willing to accept vaccination. Determinants for non-acceptance included rural or low-urban residence, not knowing vaccinated individuals, and lack of connection to the gay/queer community. Beliefs associated with acceptance included perception of higher risk/severity of the disease, higher protection motivation, positive outcome expectations, and perceived positive social norms. Respondents recommended better communication, accessible vaccination options, and inclusive vaccine offers.

FRONTIERS IN PUBLIC HEALTH (2023)

Add to Collection

Article Medicine, General & Internal

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019

Daniela K. van Santen, Rachel Sacks-Davis, Ashleigh Stewart, Anders Boyd, Jim Young, Marc van der Valk, Colette Smit, Andri Rauch, Dominique L. Braun, Inmaculada Jarrin, Juan Berenguer, Jeffrey V. Lazarus, Karine Lacombe, Maria-Bernarda Requena, Linda Wittkop, Olivier Leleux, Dominique Salmon, Fabrice Bonnet, Gail Matthews, Joseph S. Doyle, Tim Spelman, Marina B. Klein, Maria Prins, Jason Asselin, Mark A. Stoove, Margaret Hellard

Summary: We assessed the impact of broad direct-acting antiviral (DAA) access on hepatitis C virus (HCV) incidence among people living with HIV (PLHIV) and found that it can significantly reduce HCV incidence, indicating a treatment as prevention effect.

ECLINICALMEDICINE (2023)

Add to Collection

Article Infectious Diseases

A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022

Ard van Sighem, Sally Hendriks, Febe Deug, Paul Zantkuijl, Jan E. M. van Bergen, John de Wit, Janneke Heijne, Elske Hoornenborg, Tom van Benthem, Maarten F. Schim van der Loeff, Maria Prins, Udi Davidovich, Suzanne E. Geerlings, Dinah Bons, Michiel Heidenrijk, Pieter Brokx, Nina Schat, Peter Reiss, Marc van der Valk, Godelieve de Bree

Summary: The infrastructure in cities provides unique opportunities to eliminate HIV. The effort in Amsterdam through an integrated approach resulted in a significant decline in new infections and diagnoses, surpassing the UNAIDS treatment goals.

EUROSURVEILLANCE (2023)

Add to Collection

Article Gastroenterology & Hepatology

Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study

Marleen van Dijk, Anders Boyd, Sylvia M. Brakenhoff, Cas J. Isfordink, Rosan A. van Zoest, Mark D. Verhagen, Robert J. de Knegt, Joost P. H. Drenth, Marc van Der Valk

Summary: Lost to follow-up (LTFU) poses a higher risk of mortality for individuals with HCV, and in the Netherlands, those who are incarcerated/institutionalized, have low income, and have psychiatric comorbidities are more likely to become LTFU.

LIVER INTERNATIONAL (2023)

Add to Collection

Letter Gastroenterology & Hepatology

Joint statement in support of hepatitis C human challenge studies

Harvey J. Alter, Eleanor Barnes, Mia J. Biondi, Andrea L. Cox, Jake D. Eberts, Jordan J. Feld, T. Jake Liang, Josh Morrison, Charles M. Rice, Naglaa H. Shoukry, David L. Thomas, Jennifer Van Gennip, Charles Weijer

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

Add to Collection

Article Microbiology

Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case-Control Diagnostic Validation Study

Kris Hage, Marita van de Kerkhof, Anders Boyd, Joanne M. Carson, Astrid M. Newsum, Amy Matser, Marc van der Valk, Kees Brinkman, Joop E. Arends, Fanny N. Lauw, Bart J. A. Rijnders, Arne van Eeden, Marianne Martinello, Gail V. Matthews, Janke Schinkel, Maria Prins, Ivana Lazarevic, Francisco Rodriguez-Frias

Summary: This study assessed the predictive capacity of the HCV-MOSAIC risk score as a screening tool for HCV reinfection in HIV-infected men who have sex with men. The results indicate that the HCV-MOSAIC risk score may be useful for identifying individuals at risk of HCV reinfection and could guide HCV-RNA testing in sexual health or HIV-care settings.

PATHOGENS (2023)

Add to Collection

Article Immunology

Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence overtime in people living with HIV: a nationwide cohort study

Ramon P. van der Zee, Ferdinand W. N. M. Wit, Olivier Richel, Marc van der Valk, Peter Reiss, Henry J. C. de Vries, Jan M. Prins

Summary: This study examined the trends in incidence of and mortality after anal cancer diagnosis in people living with HIV in the Netherlands. The findings suggest that anal cancer incidence is slowly declining in men who have sex with men (MSM) but not in non-MSM and women. Screening for anal cancer improved survival in men diagnosed during screening. These results highlight the importance of not only focusing on MSM for anal cancer prevention.

LANCET HIV (2023)

Add to Collection

Article Nursing

Between delivering chronic care and answering patients' burdens: Understanding HIV specialist nurses' experiences in the age of treatment

Maarten Bedert, Kevin Moody, Pythia Nieuwkerk, Natasja van Holten, John de Wit, Marc van der Valk

Summary: This study aims to understand the experiences of HIV nurses in the context of ambivalence between biomedical treatment advancements and the continuing burden for people living with HIV and negative representations of HIV. Through in-depth interviews and thematic analysis, the study identified six themes related to the nurses' experiences, including the need for additional care for specific patient populations, the development of unique relationships with patients based on trust and empathy, and the increasing complexity of their tasks. The study also highlights the importance of HIV nurses in the organizational changes in HIV care and the provision of chronic care models.

JOURNAL OF ADVANCED NURSING (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.